Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

B7-mediated costimulation and the immune response

J Schultze1, L M Nadler, J G Gribben

  • 1Dana Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

Blood Reviews
|June 1, 1996
PubMed
Summary

T cells need costimulatory signals from antigen-presenting cells for activation. The B7 family (B7-1/CD80, B7-2/CD86) provides this crucial signal, impacting autoimmune disease, cancer immunity, and transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence.

Nature communications·2021
Same author

Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL.

Leukemia·2017
Same author

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial).

Leukemia·2017
Same author

Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition.

Oncogene·2016
Same author

Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial.

Leukemia·2016

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • T cell activation requires antigen presentation plus costimulatory signals.
  • Lack of costimulation leads to T cell anergy, preventing proliferation and cytokine secretion.
  • The B7 family (B7-1/CD80, B7-2/CD86) delivers critical costimulatory signals via CD28 on T cells.

Purpose of the Study:

  • To explore the role of B7 family costimulatory molecules in T cell activation.
  • To investigate the implications of B7 dysregulation in autoimmune diseases.
  • To examine the potential of targeting the B7 pathway for cancer immunotherapy and transplantation.

Main Methods:

  • Review of recent evidence on B7 family function.
  • Analysis of the impact of B7 expression on T cell responses.
  • Discussion of therapeutic strategies involving the B7/CD28 pathway.

Related Experiment Videos

Main Results:

  • B7-1 and B7-2 provide essential costimulation to T cells through CD28.
  • Dysregulated B7 expression is linked to autoimmune pathogenesis.
  • Lack of B7 on tumors may contribute to immune evasion.

Conclusions:

  • The B7/CD28 pathway is pivotal in T cell immunity.
  • Targeting B7 offers potential for cancer immunotherapy by enhancing anti-tumor responses.
  • Modulating B7 interactions can prevent graft rejection and graft-versus-host disease in transplantation.